Study of 237 SLE pts shows mood disorders, fibromyalgia & chronic damage were major determinants of poorer Quality of life in SLE. mean SLEDAI-2k was 1.7, 29% had FM; 44% had chronic damage. https://t.co/JHzmleVMIK https://t.co/Sqk9K6oA7M

• Fibromyalgia, mood disorders and chronic damage are the main determinants of wo…

🔍 Safety of a JAKi Across 15,000 Patient-Years of Data Now in the RheumNow poster hall: Safety outcomes with a JAKi from 11 Phase 3 trials in adult patients with RA, PsA, AS, and nr-axSpA. Sponsored by AbbVie US Medical Affairs. https://t.co/yeif38wKIY https://t.co/earZnqZLSI

• Safety of a JAKi Across 15,000 Patient-Years of Data | RheumNow

Don’t use ‘biopsy-proven’ to label sarcoidosis; use ‘biopsy supported’ as there are many causes of granulomatous inflammation. It’s happened to one of my pts who was diagnosed with “biopsy-proven” sarcoidosis - she actually had CVID with GLILD. #ACRReview #ACR24 https://t.co/it41va1K6g

• https://x.com/KDAO2011/status/1857436330428424654/photo/1

Summary of treatments in psoriatic arthritis #PsA @RheumNow #ACR24 https://t.co/EybzRCPLtA

• https://x.com/synovialjoints/status/1857419269358666103/photo/1

What is Osteoarthritis? A downloadable patient education page from JAMA. https://t.co/gocsQizJUh https://t.co/4bBuNUAYlR

• Patient Information: Knee Osteoarthritis

RheumNow’s expanded coverage of the #ACR24 Annual meeting is sponsored in part by Novartis. All content is chosen by RheumNow & its faculty.